Figure 6
Figure 6. Platelet CD40L contributes to the progression of established plaques. Seventeen-week-old Apoe−/− mice were injected with activated Cd40l+/+Apoe−/− or Cd40l−/−Apoe−/− platelets, or vehicle once every 5 days for 12 weeks. (A) Plaque area was quantified in the aortic arch and main branch points at 29 weeks and compared with the baseline lesion size of 17-week-old Apoe−/− mice. (B-E) Representative longitudinal sections (hematoxylin and eosin staining; n = 8/group). *P < .05 vs Cd40l+/+Apoe−/−. Scale bars represent 200 μm.

Platelet CD40L contributes to the progression of established plaques. Seventeen-week-old Apoe−/− mice were injected with activated Cd40l+/+Apoe−/− or Cd40l−/−Apoe−/− platelets, or vehicle once every 5 days for 12 weeks. (A) Plaque area was quantified in the aortic arch and main branch points at 29 weeks and compared with the baseline lesion size of 17-week-old Apoe−/− mice. (B-E) Representative longitudinal sections (hematoxylin and eosin staining; n = 8/group). *P < .05 vs Cd40l+/+Apoe−/−. Scale bars represent 200 μm.

Close Modal

or Create an Account

Close Modal
Close Modal